Elevation Oncology, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
ELEV on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
101 Federal Street, Suite 1900, Boston, MA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Elevation Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Qiming U.S. Healthcare Fund II, L.P. 10%+ Owner $1.21M Jun 29, 2021
Vertex Global HC Fund II Pte. Ltd. 10%+ Owner $1.18M Jun 29, 2021
Cormorant Asset Management, LP Former 10% Owner $1.14M Jun 29, 2021
venBio Global Strategic Fund III, L.P. 10%+ Owner $972K May 25, 2022
Joseph J. Ferra Jr CHIEF EXECUTIVE OFFICER, Director $271K Dec 16, 2024
Valerie Malyvanh Jansen Chief Medical Officer $194K Feb 15, 2024
Timothy P. Clackson Director $24.1K Jun 13, 2024
David Dornan Chief Scientific Officer $19.1K Feb 15, 2024
Tammy Furlong Chief Financial Officer $16.9K Nov 15, 2024
Alan B. Sandler Director Jun 13, 2024
R. Michael Carruthers Director Jun 13, 2024
Julie M. Cherrington Director Jun 13, 2024
Steve Elms Director Jun 13, 2024
Aisling Capital IV, LP 10%+ Owner Jun 16, 2023
Colin Walsh Director Jun 16, 2023
Lori Hu Director Jun 16, 2023
Richard Gaster Director Jun 24, 2021
Shawn Leland President, CEO, Director Feb 14, 2022
Darcy Mootz Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Elevation Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.